Jefferies Financial Group’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-599,042
| Closed | -$3.25M | – | 1588 |
|
|
2024
Q4 | $3.25M | Sell |
599,042
-23,431
| -4% | -$127K | 0.02% | 371 |
|
|
2024
Q3 | $4.49M | Buy |
622,473
+330,348
| +113% | +$2.39M | 0.03% | 231 |
|
|
2024
Q2 | $3.17M | Buy |
292,125
+54,056
| +23% | +$587K | 0.03% | 300 |
|
|
2024
Q1 | $4.46M | Buy |
238,069
+109,269
| +85% | +$2.05M | 0.04% | 219 |
|
|
2023
Q4 | $2.79M | Buy |
128,800
+104,800
| +437% | +$2.27M | 0.02% | 369 |
|
|
2023
Q3 | $494K | Buy |
+24,000
| New | +$494K | ﹤0.01% | 706 |
|
|
2023
Q1 | – | Sell |
-13,750
| Closed | -$524K | – | 1374 |
|
|
2022
Q4 | $524K | Buy |
+13,750
| New | +$524K | ﹤0.01% | 649 |
|